2002
DOI: 10.1159/000053005
|View full text |Cite
|
Sign up to set email alerts
|

Transdermal Estradiol in Menopausal Women Depresses Interleukin-6 without Affecting Other Markers of Immune Response

Abstract: Objective: The aim of this study was to analyze the effect of transdermal estradiol replacement therapy (HRT) on immune function in menopausal women. Study Design: A prospective comparative study was carried out in 30 women, aged 48–55 years, who were divided into two groups; 20 of them received transdermal estradiol 50 µg/day during 3 months and 10 who refused to receive HRT served as controls. Serum interleukins were quantified by specific immunoenzymatic assays; in addition, hormones of somatotropin axis a… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

3
28
0
1

Year Published

2006
2006
2012
2012

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 45 publications
(32 citation statements)
references
References 19 publications
3
28
0
1
Order By: Relevance
“…However, Alvarez-Tutor et al (1999) described a persistent increase of prolactin levels after oral etinyl-E2 treatment. Other studies observed no alterations in prolactin levels after transdermal estrogen treatment (Saucedo et al 2002) or a consistent decrease after oral as well as transdermal treatment (Castelo-Branco et al 1993).…”
Section: Figurementioning
confidence: 92%
“…However, Alvarez-Tutor et al (1999) described a persistent increase of prolactin levels after oral etinyl-E2 treatment. Other studies observed no alterations in prolactin levels after transdermal estrogen treatment (Saucedo et al 2002) or a consistent decrease after oral as well as transdermal treatment (Castelo-Branco et al 1993).…”
Section: Figurementioning
confidence: 92%
“…Additional studies have reported that post-menopausal women (between the age of 52 and 70) taking HT for at least 12 months prior to the study have increased numbers of B cells and better T-cell proliferative responses than post-menopausal women who are not undergoing any HT (Porter et al 2001). Moreover, post-menopausal women (>48 years and time since menopause >1.6 years) have higher plasma levels of the inflammatory cytokines TNFα and IFNγ compared to pre-menopausal subjects (Deguchi et al 2001;Vural et al 2006a;Vural et al 2006b), and HT results in a decrease in serum level of TNFα (Vural et al 2006a), IFNγ (Deguchi et al 2001), and IL-6 (Saucedo et al 2002). Similarly, ovariectomy increases IL-6 plasma levels in adult female rhesus macaque, and this change is reversed upon estradiol administration (Keller et al 2001).…”
Section: Introductionmentioning
confidence: 99%
“…Postmenopausal women without HRT were found to experience greater muscle damage, indicating a possible protective effect of HRT against exercise-induced skeletal muscle damage, during which mRNA expression of IL-6, IL-8 and IL-15 changed markedly in the control group compared with the HRT group (Dieli-Conwright et al, 2009). In a clinical trial to investigate the effects of HRT on immune function in menopausal women the researchers found significant alterations on the interleukin levels (Saucedo et al, 2002). Estrogen/progesterone HRT has been demonstrated to affect cell-mediated immunity, thus being a potential factor influencing development and course of autoimmune disorders and neoplastic diseases (Stopinska-Gluszak et al, 2006).…”
Section: Discussionmentioning
confidence: 99%